Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029

The global market for amyotrophic lateral sclerosis devices or motor neuron disease devices anticipated to reach $19.5 billion by 2029, growing at a CAGR of 7.3% over the forecast period, driven by increasing incidence, rising geriatric population, lack of curative treatment, growing public awareness, and technological advancements in palliative care.

https://www.ihealthcareanalyst.com/global-amyotrophic-lateral-sclerosis-devices-market/

Amyotrophic lateral sclerosis or Lou Gehrig's disease or motor neuron disease (MND) is characterized by progressive degeneration of the motor nerve cells in the brain and spinal cord. Nearly 90% of patients with MND have the mixed ALS form of the disease, so that the terms MND and ALS are commonly used to mean the same thing. Amyotrophic lateral sclerosis, progressive muscular atrophy (PMA), progressive bulbar palsy (PBP) and primary lateral sclerosis (PLS) are all subtypes of motor neuron disease.

The global market for amyotrophic lateral sclerosis devices research report provides market size ($million 2019 to 2029), market share analysis, growth trends and forecast (CAGR%, 2022 to 2029).

The global market for amyotrophic lateral sclerosis devices segmented by product - airway and pulmonary management devices [anesthesia and respiratory masks, pulmonary function diagnostic devices (spirometry devices, others), ventilators (positive airway pressure devices, other devices), other devices], drug/fluid delivery and infusion therapy devices [inhalation devices (nebulizers)], and geography.

The global motor neuron disease (MND) devices market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

Major competitors operating in the global market for motor neuron disease devices and profiled in this report include Ambu A/S, Becton, Dickinson and Company (CareFusion Corporation), Intersurgical, Inc., Medline Industries, Inc., Medtronic plc (Covidien plc), Smiths Medical, Inc., and Teleflex, Inc.

Product
Airway and Pulmonary Management Devices
Anesthesia and Respiratory Masks
Pulmonary Function Diagnostic Devices
Spirometry Devices
Others
Ventilators
Positive Airway Pressure Devices
Other Devices
Other Devices
Drug/Fluid Delivery and Infusion Therapy Devices
Inhalation Devices
Nebulizers

Geography
North America (U.S., Canada)
Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
Asia Pacific (Japan, China, India, Rest of APAC)
Latin America (Brazil, Mexico, Rest of LA)
Rest of the World

Company Profiles
Ambu A/S
Becton, Dickinson and Company (CareFusion Corporation)
Intersurgical, Inc.
Medline Industries, Inc.
Medtronic plc (Covidien plc)
Smiths Medical, Inc.
Teleflex, Inc.

To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/amyotrophic-lateral-sclerosis-devices-market/

iHealthcareAnalyst, Inc.
Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
Phone: +1 (314) 315-4764,
Email: info@ihealthcareanalyst.com

iHealthcareAnalyst, Inc. is a specialized healthcare market research and consulting company providing industry analysis and competitive intelligence services to global clients. The company publishes syndicated, custom and consulting grade reports covering animal health, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, hospital equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client's specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

This release was published on openPR.